Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors - PR Newswire -BoardProspects

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

PR Newswire Apr 1 2021 BoardMoves

HAMILTON, ON and BOSTON, April 1, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines today announced the appointment of Donald A. Bergstrom, M.D., Ph.D., as a member of the Company's Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Astoria Financial Corporation Announces The Resignation Of Chairman George L. Engelke, Jr. And The Appointment Of ... also published in PR Newswire
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Former Aes Ceo Paul Hanrahan Elected to Arch Coal's Board of Directors also published in PR Newswire
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned